Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AIM ImmunoTech Inc. (HEB)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
        Gain on sale of investments, net         -0.3
Total non-interest income         -0.3
Pre-tax income before non-recurring items  -19.4-17.1-14.3-9.4-9.8-8.3-7.5-15.2
Non-recurring items  0.02.0      
Asset impairment    0.1     
Pre-tax income  -19.4-19.1-14.4-9.4-9.8-8.3-7.5-15.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -19.4-19.1-14.4-9.4-9.8-8.3-7.5-15.2
            Net margin  -13790.8%-14168.1%-8834.4%-6717.1%-2677.7%-1889.9%-8154.3%-11451.1%
   
Basic EPS  ($0.40)($0.40)($0.45)($2.58)($9.78)($0.29)($0.34)($0.77)
Diluted EPS  ($0.40)($0.40)($0.45)($2.58)($9.78)($0.29)($0.34)($0.77)
   
Shares outstanding (basic)  48.647.831.83.61.028.721.819.7
Shares outstanding (diluted)  48.647.831.83.61.028.721.819.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy